JUNSHI BIO (688180.SH): Shanghai Tan Ying plans to reduce its shareholding by no more than 2%
Junshi Biosciences (688180.SH) announced that Shanghai Tan Ying is optimistic about the company's long-term development. Due to the fund's tenure and liquidity arrangements, it plans to reduce its holding of the company's shares through block trading by no more than 20,533,800 shares, with the reduction not exceeding 2% of the total share capital.
JUNSHI BIO (688180.SH) announced that Shanghai Tan Ying is optimistic about the company's long-term development. Due to fund term and liquidity arrangements, they plan to reduce their holdings in the company by no more than 20.53 million shares through block trades, with a reduction ratio not exceeding 2% of the total share capital of the company.
Related Articles
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
US Stock Market Move | AI application software stocks rise, Applovin (APP.US) up more than 6%
US Stock Market Move | Orforglipron's oral weight-loss drug program achieves success in Phase III trial, causing Eli Lilly (LLY.US) stock to rise more than 3%.
US Stock Market Move | Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) rose more than 3%. Morgan Stanley predicts that the company's gross profit margin will surpass 60% in the fourth quarter.
